Global In-vitro Diagnostic Services Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by In-vitro Diagnostic Services Revenue
• 1.4 Market 4
  • 1.4.1 Global In-vitro Diagnostic Services Market Size Growth Rate 4: 2020 VS 2026
  • 1.4.2 Infectious Testing
  • 1.4.3 Diabetes Testing
  • 1.4.4 Molecular Testing
  • 1.4.5 Tissue Testing
• 1.5 Market by Application
  • 1.5.1 Global In-vitro Diagnostic Services Market Share 4: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Point-Of-Care Testing
  • 1.5.4 Laboratories
  • 1.5.5 Academic Institutes
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global In-vitro Diagnostic Services Market Perspective (2015-2026)
• 2.2 Global In-vitro Diagnostic Services Growth Trends by Regions
  • 2.2.1 In-vitro Diagnostic Services Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 In-vitro Diagnostic Services Historic Market Share by Regions (2015-2020)
  • 2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 In-vitro Diagnostic Services Market Growth Strategy
  • 2.3.6 Primary Interviews with Key In-vitro Diagnostic Services Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top In-vitro Diagnostic Services Players by Market Size
  • 3.1.1 Global Top In-vitro Diagnostic Services Players by Revenue (2015-2020)
  • 3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global In-vitro Diagnostic Services Market Concentration Ratio
  • 3.2.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2019
• 3.3 In-vitro Diagnostic Services Key Players Head office and Area Served
• 3.4 Key Players In-vitro Diagnostic Services Product Solution and Service
• 3.5 Date of Enter into In-vitro Diagnostic Services Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size 4 (2015-2026)

• 4.1 Global In-vitro Diagnostic Services Historic Market Size 4 (2015-2020)
• 4.2 Global In-vitro Diagnostic Services Forecasted Market Size 4 (2021-2026)

5 Market Size 4 (2015-2026)

• 5.1 Global In-vitro Diagnostic Services Market Size 4 (2015-2020)
• 5.2 Global In-vitro Diagnostic Services Forecasted Market Size 4 (2021-2026)

6 North America

• 6.1 North America In-vitro Diagnostic Services Market Size (2015-2020)
• 6.2 In-vitro Diagnostic Services Key Players in North America (2019-2020)
• 6.3 North America In-vitro Diagnostic Services Market Size 4 (2015-2020)
• 6.4 North America In-vitro Diagnostic Services Market Size 4 (2015-2020)

7 Europe

• 7.1 Europe In-vitro Diagnostic Services Market Size (2015-2020)
• 7.2 In-vitro Diagnostic Services Key Players in Europe (2019-2020)
• 7.3 Europe In-vitro Diagnostic Services Market Size 4 (2015-2020)
• 7.4 Europe In-vitro Diagnostic Services Market Size 4 (2015-2020)

8 China

• 8.1 China In-vitro Diagnostic Services Market Size (2015-2020)
• 8.2 In-vitro Diagnostic Services Key Players in China (2019-2020)
• 8.3 China In-vitro Diagnostic Services Market Size 4 (2015-2020)
• 8.4 China In-vitro Diagnostic Services Market Size 4 (2015-2020)

9 Japan

• 9.1 Japan In-vitro Diagnostic Services Market Size (2015-2020)
• 9.2 In-vitro Diagnostic Services Key Players in Japan (2019-2020)
• 9.3 Japan In-vitro Diagnostic Services Market Size 4 (2015-2020)
• 9.4 Japan In-vitro Diagnostic Services Market Size 4 (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia In-vitro Diagnostic Services Market Size (2015-2020)
• 10.2 In-vitro Diagnostic Services Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia In-vitro Diagnostic Services Market Size by Type (2015-2020)
• 10.4 Southeast Asia In-vitro Diagnostic Services Market Size by Application (2015-2020)

11 India

• 11.1 India In-vitro Diagnostic Services Market Size (2015-2020)
• 11.2 In-vitro Diagnostic Services Key Players in India (2019-2020)
• 11.3 India In-vitro Diagnostic Services Market Size by Type (2015-2020)
• 11.4 India In-vitro Diagnostic Services Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America In-vitro Diagnostic Services Market Size (2015-2020)
• 12.2 In-vitro Diagnostic Services Key Players in Central & South America (2019-2020)
• 12.3 Central & South America In-vitro Diagnostic Services Market Size by Type (2015-2020)
• 12.4 Central & South America In-vitro Diagnostic Services Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 BioRad
  • 13.1.1 BioRad Company Details
  • 13.1.2 BioRad Business Overview
  • 13.1.3 BioRad In-vitro Diagnostic Services Introduction
  • 13.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2015-2020))
  • 13.1.5 BioRad Recent Development
• 13.2 DexCom
  • 13.2.1 DexCom Company Details
  • 13.2.2 DexCom Business Overview
  • 13.2.3 DexCom In-vitro Diagnostic Services Introduction
  • 13.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.2.5 DexCom Recent Development
• 13.3 Nova Biomedical
  • 13.3.1 Nova Biomedical Company Details
  • 13.3.2 Nova Biomedical Business Overview
  • 13.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
  • 13.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.3.5 Nova Biomedical Recent Development
• 13.4 OraSure
  • 13.4.1 OraSure Company Details
  • 13.4.2 OraSure Business Overview
  • 13.4.3 OraSure In-vitro Diagnostic Services Introduction
  • 13.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.4.5 OraSure Recent Development
• 13.5 Pearl Pathways
  • 13.5.1 Pearl Pathways Company Details
  • 13.5.2 Pearl Pathways Business Overview
  • 13.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
  • 13.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.5.5 Pearl Pathways Recent Development
• 13.6 Phenomenex
  • 13.6.1 Phenomenex Company Details
  • 13.6.2 Phenomenex Business Overview
  • 13.6.3 Phenomenex In-vitro Diagnostic Services Introduction
  • 13.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.6.5 Phenomenex Recent Development
• 13.7 Qiagen
  • 13.7.1 Qiagen Company Details
  • 13.7.2 Qiagen Business Overview
  • 13.7.3 Qiagen In-vitro Diagnostic Services Introduction
  • 13.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.7.5 Qiagen Recent Development
• 13.8 Roche Diagnostics
  • 13.8.1 Roche Diagnostics Company Details
  • 13.8.2 Roche Diagnostics Business Overview
  • 13.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
  • 13.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.8.5 Roche Diagnostics Recent Development
• 13.9 Siemens
  • 13.9.1 Siemens Company Details
  • 13.9.2 Siemens Business Overview
  • 13.9.3 Siemens In-vitro Diagnostic Services Introduction
  • 13.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.9.5 Siemens Recent Development
• 13.10 Sysmex
  • 13.10.1 Sysmex Company Details
  • 13.10.2 Sysmex Business Overview
  • 13.10.3 Sysmex In-vitro Diagnostic Services Introduction
  • 13.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 13.10.5 Sysmex Recent Development
• 13.11 Thermofisher
  • 10.11.1 Thermofisher Company Details
  • 10.11.2 Thermofisher Business Overview
  • 10.11.3 Thermofisher In-vitro Diagnostic Services Introduction
  • 10.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2015-2020)
  • 10.11.5 Thermofisher Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer